News
SelectScience TV interviews Ashley Cooper of Reinnervate at SBS
05 / 05 / 2011
Ashley Cooper discusses the launch of the second wave of Alvetex® products for 3D cell culture with SelectScience TV. To watch the interview and learn how Alvetex® products enables the routine 3D culture of a wide variety of cell types click the image below.
Reinnervate Ltd to be present at the Beatson Cancer…
Reinnervate Ltd will be present at the Beatson Cancer Conference in Glasgow on 10th July 2013. Representatives from Reinnervate will be on hand to present and discus the…
> read more
Reinnervate and Promega to present 3D cell culture…
Reinnervate Ltd and Promega Corp. will present a series of joint seminars on the US West coast in June 2013. Seminars will take place in San Diego (Tuesday 11th June), Seattle (Wednesday…
> read more
3rd Cell-Based Assays event 18th - 19th March 2013,…
Professor Stefan Przyborski, founder and Chief Scientific Officer of Reinnervate will present on Alvetex Technology That Enables Routine 3D Cell Culture, at 2pm on 18th March at ULU University of…
> read more
ELRIG Research & Innovation 19th March 2013
Richard Rowling Commercial Director of Reinnervate will present on Target-based drug activity and post-translational and transcriptional analysis using ex vivo Alvetex®Scaffold three-dimensional…
> read more
Reinnervate to Exhibit at the American Association…
Reinnervate will exhibit at the American Association for Cancer Research, Annual Meeting, 6th – 10th April, at the Walter E, Washington Convention Centre, Washington, DC.
Discover…
3D cell culture firm Reinnervate and specialist Oncology…
3D cell culture firm Reinnervate and specialist Oncology CRO Oncotest GmbH enter collaboration agreement. Oncotest to offer enhanced pre-clinical oncology and cancer research screening services incorporating…
> read more
3D cell culture firm Reinnervate announce the release…
Sedgefield, UK. November 2012 - Market leading 3D cell culture company, Reinnervate Ltd, today announced that it has launched and commenced shipments of Alvetex®Scaffold 96 well plates to customers.
Reinnervate to Exhibit at the American Society for…
Reinnervate are exhibiting at the American Society for Cell Biology Annual Conference to be held in San Francisco, California. We would be delighted to welcome you at booth 1017-1019 to discuss our…
> read more
New evidence-based 3D cell culture web portal launched…
Sedgefield, UK. October 2012 – Reinnervate Ltd, the developers of Alvetex®Scaffold for 3D cell culture, today announced the launch of a new 3D cell culture portal for scientists in the life…
> read more
Medicyte GmbH and Reinnervate Ltd to collaborate on…
Heidelberg, Germany and Sedgefield, UK. 9th July 2012 - Two market leading companies in the field of cell based assays and predictive toxicology today announced a new product collaboration. Medicyte…
> read more
Top award for 3D cell culture pioneer, Stefan Przyborski,…
Sedgefield, UK. June 2012 – Prof Stefan Przyborski, CSO and founder of Reinnervate Ltd has been recognised with a top award from the Royal Society of Chemistry.
The Rita and John…
Reinnervate and Tecan to develop automated 3D cell…
Sedgefield, UK and Männedorf, Switzerland. 7 June 2012. Reinnervate Ltd and Tecan Trading AG, have signed a co-marketing agreement to develop a range of automated solutions for 3D cell culture,…
> read more
Reinnervate Ltd and Roslin Cellab announce plans to…
Sedgefield, UK. April 2012. Reinnervate Ltd and Roslin Cellab, two leading UK companies in the fields of 3D cell culture and stem cell biology, today announced that they will join…
> read more
Reinnervate Ltd announce Kirkstall Ltd collaboration
Reinnervate (inventors of alvetex®scaffold) and Kirkstall (developers of the Quasi-Vivo® system) today announced that they will collaborate to bring next generation three…
> read more
Reinnervate and Mirus Bio announce collaboration with…
Sedgefield, UK. November 2011. Reinnervate (Sedgefield, UK) and Mirus Bio (Madison, USA) today announced a commercial agreement to launch a new range of products for the transfection…
> read more
Reinnervate Expands its Distribution Network for alvetex®…
Sedgefield, UK. October 2011. Reinnervate, the emerging global leader in the rapidly growing 3D cell culture market, is delighted to announce it has signed agreements with seven new European distributors…
> read more
alvetex® voted one of most technologically…
Sedgefield, UK. 23rd June 2011. Reinnervate, an innovative life sciences company driving the adoption of routine 3D cell culture, is delighted to announce that alvetex®, its breakthrough…
> read more
Reinnervate partners with AMS Biotechnology (Europe)…
Sedgefield, UK. 31 May 2011. Reinnervate, an innovative life sciences company driving the adoption of routine 3D cell culture, is delighted to announce that it is partnering with AMS Biotechnology…
> read more
SelectScience TV interviews Ashley Cooper of Reinnervate…
Ashley Cooper discusses the launch of the second wave of Alvetex® products for 3D cell culture with SelectScience TV. To watch the interview and learn how Alvetex® products…
> read more
Reinnervate to launch alvetex® in the…
Sedgefield, UK. 11th March 2011. Reinnervate, an innovative life sciences company driving the adoption of routine 3D cell culture, is delighted to announce the upcoming US launch of alvetex®…
> read more
Reinnervate enhances commercial and product development…
Sedgefield, UK. 8th March 2011. Reinnervate, the life sciences company driving the adoption of routine 3D cell culture, is delighted to announce the appointments of Richard Rowling as Commercial Director…
> read more
Alvetex® named in the top ten life…
Sedgefield, UK. 1st December 2010 Reinnervate, an innovative life sciences company driving the adoption of routine 3D cell culture, is proud to announce that alvetex®, its breakthrough…
> read more
Reinnervate partners with LGC for global distribution…
Sedgefield, UK. 29th November 2010. Reinnervate, an innovative life sciences company driving the adoption of routine 3D cell culture, is delighted to announce that it is partnering with LGC Standards…
> read more
Reinnervate launches alvetex®, a breakthrough…
Sedgefield, UK. 22nd November 2010. Reinnervate, an innovative life sciences company driving the adoption of routine 3D cell culture, is very pleased to announce today the first commercial launch…
> read more
Reinnervate gears up for the launch of alvetex®…
Sedgefield, UK. 18th November 2010. Reinnervate, an innovative life sciences company driving the adoption of routine 3D cell culture, today announced the appointment of Classic Industries Europe for…
> read more
Reinnervate completes expansion into new purpose-built…
Sedgefield, UK. 16th November 2010 Reinnervate, an innovative life sciences company driving the adoption of routine 3D cell culture, today announced its expansion into a new purpose-built research…
> read more
Reinnervate to speak at the Cell-based Assays Conference…
reinnervate is pleased to announce that Professor Stefan Przyborski, reinnervate’s founder and Chief Scientific Officer, will be presenting at the third annual conference on Cell-based Assays…
> read more
Reinnervate launches new website with interactive…
Sedgefield, UK. 7th October 2010 reinnervate, an innovative life sciences company driving the adoption of routine 3D cell culture, today announced the launch of its new, fully interactive website…
> read more
Reinnervate wins Chemistry Innovation / EPSRC Industrial…
Reinnervate has been granted a Chemistry Innovation Knowledge Transfer Network / EPSRC Industrial CASE Award to fund the development of a next-generation Alvetex® scaffold…
> read more
Reinnervate has been accepted as a new member of the…
Reinnervate has been accepted as a new member of the In Vitro Testing Industrial Platform (IVTIP – www.ivtip.org). The Company joins…
> read more
Reinnervate secures £1.8 million of investment to…
Sedgefield, UK. 27th May 2010. Reinnervate, the life sciences company driving the adoption of routine 3D cell culture, today announced that it had successfully raised £1.8 million in new equity…
> read more
Join Our Mail List